Cargando…

Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions

INTRODUCTION: A wide variety of fractionation schedules have been employed for the treatment of early glottic cancer. The aim is to report our 10-year experience of using hypofractionated radiotherapy with 55Gy in 20 fractions at 2.75Gy per fraction. METHODS: Patients treated between 2004 and 2013 w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ermiş, Ekin, Teo, Mark, Dyker, Karen E., Fosker, Chris, Sen, Mehmet, Prestwich, Robin JD
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580345/ https://www.ncbi.nlm.nih.gov/pubmed/26395876 http://dx.doi.org/10.1186/s13014-015-0505-6

Ejemplares similares

Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction
por: Lee, Tae Hoon, et al.
Publicado: (2022)

Definitive and adjuvant radiotherapy for sinonasal squamous cell carcinomas: a single institutional experience
por: Duru Birgi, Sumerya, et al.
Publicado: (2015)

Poor local control of ulcerative T1 glottic cancer treated with 2.25-Gy per fraction radiotherapy
por: Oie, Yumi, et al.
Publicado: (2021)

Accuracy of [(18)Fluorine]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography-Computed Tomography Response Assessment Following (Chemo)radiotherapy for Locally Advanced Laryngeal/Hypopharyngeal Carcinoma
por: Slevin, Finbar, et al.
Publicado: (2017)

Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer—A Multicenter Study
por: Elicin, Olgun, et al.
Publicado: (2019)

Hypofractionated High-Dose Intensity-Modulated Radiotherapy (60 Gy at 2.5 Gy per Fraction) for Recurrent Renal Cell Carcinoma: A Case Report
por: Cho, Jaeho, et al.
Publicado: (2008)

Hypofractionated (2.75 Gy per fraction) versus Conventionally Fractionated Primary Radiotherapy for T2N0M0 Carcinoma of the Glottis
por: Kovarik, Josef, et al.
Publicado: (2022)

Hypofractionated radiotherapy for early glottic cancer: a retrospective interim analysis of a single institution
por: Lee, Jeong Won, et al.
Publicado: (2019)

Three-week hypofractionated radiotherapy in early glottic cancer—a single institution retrospective study
por: Sudha, Arun Sankar, et al.
Publicado: (2022)

Randomized Pilot Study of 20 Gy in 5 Fractions versus 27 Gy in 3 Fractions Radiotherapy for Treating Painful Bone Metastases: A Single Institution Experience
por: Sakr, Amr, et al.
Publicado: (2020)

A multicenter survey of stage T1 glottic cancer treated with radiotherapy delivered in 2.25-Gy fractions in clinical practice: An initial 5-year analysis
por: Itoh, Yoshiyuki, et al.
Publicado: (2016)

Hypofractionated helical tomotherapy (75 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term analysis of gastrointestinal and genitourinary toxicity
por: Kong, Moonkyoo, et al.
Publicado: (2014)

Definitive radiotherapy for early stage glottic cancer by 6 MV photons
por: Tong, Chi-Chung, et al.
Publicado: (2012)

Cost-effectiveness of hypofractionated versus conventional fractionated radiotherapy for the treatment of men with early glottic cancer: a study in the Brazilian public and private health system
por: Lourenção, Marina, et al.
Publicado: (2023)

Definitive radiotherapy for early (T1-T2) Glottic Squamous cell carcinoma: a 20 year Cleveland clinic experience
por: Khan, Mohammad K, et al.
Publicado: (2012)

Definitive Radiation Therapy for Early Glottic Cancer: Experience of Two Fractionation Schedules
por: Kim, Tae Gyu, et al.
Publicado: (2012)

Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis
por: Yao, Lihong, et al.
Publicado: (2020)

Predicting risk factors for hypothyroidism after definitive radiotherapy for early glottic carcinomas
por: Okubo, Mitsuru, et al.
Publicado: (2022)

Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine Metastasis
por: Shin, Jacob Y., et al.
Publicado: (2022)

Treatment outcome of localized prostate cancer by 70 Gy hypofractionated intensity-modulated radiotherapy with a customized rectal balloon
por: Kim, Hyunjung, et al.
Publicado: (2014)

Study Protocol: Prospective Study of Concurrent Chemoradiotherapy with S-1 and Hypofractionated Radiotherapy for Outpatients with Early Glottic Squamous Cell Carcinomas
por: Kimura, Kana, et al.
Publicado: (2018)

A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer
por: Lee, Sea-Won, et al.
Publicado: (2016)

Radiotherapy for Head and Neck Cancer: Evaluation of Triggered Adaptive Replanning in Routine Practice
por: Figen, Metin, et al.
Publicado: (2020)

Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis
por: Yamashita, Hideomi, et al.
Publicado: (2017)

Radiotherapy with fraction size of 2.25 Gy in T1-2 laryngeal and hypopharyngeal cancer
por: Karasawa, Kumiko, et al.
Publicado: (2013)

Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions
por: Jiang, Huayong, et al.
Publicado: (2021)

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy
por: Oksuz, Didem C, et al.
Publicado: (2011)

Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure
por: Lim, Yu Jin, et al.
Publicado: (2015)

High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study
por: Liu, Yue-E, et al.
Publicado: (2013)

Comparison of once daily radiotherapy to 60 Gy and twice daily radiotherapy to 45 Gy for limited stage small-cell lung cancer
por: Han, Dan, et al.
Publicado: (2015)

Acute and sub-acute toxicity profile of ultra-hypofractionated low-dose total skin electron beam with two 4 Gy fractions for cutaneous T cell lymphoma
por: Rolf, Daniel, et al.
Publicado: (2020)

Single institution outcomes of conventional (1.8–2 Gy/Fr) and hypofractionated (2.5–3 Gy/Fr) RT in OG/GOJ cancers during COVID-19
por: Lee, CL, et al.
Publicado: (2022)

EXTERNAL BEAM RADIOTHERAPY FOR PAINFUL BONE METASTASES FROM HEPATOCELLULAR CARCINOMA: MULTIPLE FRACTIONS COMPARED WITH AN 8-GY SINGLE FRACTION
por: HAYASHI, SHINYA, et al.
Publicado: (2014)

Hypofractionated Post-Prostatectomy Radiotherapy in 16 Fractions: A Single-Institution Outcome
por: Dubinsky, Pavol, et al.
Publicado: (2023)

Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial
por: Lin, Qiang, et al.
Publicado: (2013)

Radiotherapy Versus Cordectomy in the Management of Early Glottic Cancer
por: Chung, Seung Yeun, et al.
Publicado: (2018)

Optimized radiotherapy treatment strategy for early glottic carcinoma
por: Ono, Tamami, et al.
Publicado: (2023)

Comparison  of  efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma
por: Lyu, Jiahua, et al.
Publicado: (2019)

Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study
por: Aoki, Shuri, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k81k37bgj5v6109gj5fgngv7rn